Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

Tue, 21.10.2025       Teva

TEL AVIV, Israël, 21 oct. 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, une filiale de Teva Pharmaceutical Industries Ltd. (NYSE et TASE : TEVA), a conclu un accord de licence avec Prestige Biopharma, pour la commercialisation de Tuznue® (trastuzumab), un biosimilaire d’Herceptin®, sur la plupart des marchés européens....